Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3

K-Number: K992829 · 1999-11-22

ApplicantMedical Analysis Systems, Inc.
Decision Date1999-11-22
Product CodeGGN
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3 is the device name listed in this FDA 510(k) record. The listed applicant is Medical Analysis Systems, Inc.. It received FDA 510(k) clearance on 1999-11-22 under 510(k) number K992829. The device is classified under product code GGN. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3?

CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3 is a medical device that received FDA 510(k) clearance on 1999-11-22. The listed applicant is Medical Analysis Systems, Inc.. The 510(k) number is K992829.

When did CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3 receive FDA 510(k) clearance?

CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3 received FDA 510(k) clearance on 1999-11-22, under 510(k) number K992829.

Who is the listed applicant for CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3?

The FDA 510(k) record lists Medical Analysis Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3?

The FDA product code for CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3 is GGN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Medical Analysis Systems, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K042717MAS, DADE AND LIQUID ASSAYED DIABETES CONTROLK041194ABBOTT ARCHITECT STAT TROPONIN I LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL L, M AND HK040880MAS CARDIOIMMUNE TL LIQUID ASSAYED CARDIAC MARKER CONTROL, LEVELS 1,2 AND 3K032826MAS PAR TDMK032335MAS CARDIOIMMUNE PROBNP, MAS CARDIOIMMUNE TLK031890MAS BILIRUBIN LIQUID ASSAYED BILIRUBIN CONTROL

View all 107 devices →

Related Devices (Code: GGN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K170864VALIDATE D-Dimer Calibration Verification / Linearity Test KitMaine Standards Company, LLCK163498VALIDATE Heparin Calibration Verification/Linearity Test KitMaine Standards Company, LLCK161316George King Coumadin PlasmaGeorge King Bio-Medical, Inc.K162705VALIDATE® D-Dimer Calibration Verification/ Linearity Test KitMaine Standards Company, LLCK152961VALIDATE D-Dimer Calibration Verification/Linearity Test KitMaine Standards Company, LLCK150144VisuCon-F Low Fibrinogen Control PlasmaAffinity Biologicals, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑